The biennial conference will take place on January 23-25, 2024, in Athens, Greece.
The Global Organization for EPA and DHA Omega-3s (GOED; Salt Lake City, UT) has opened registration for its 2024 GOED Exchange event. The biennial conference will take place on January 23-25, 2024, in Athens, Greece.
The three-day event will host executives throughout the global supply chain for omega-3s. The event will feature both networking and education sessions. This year’s even theme is “Collaborating Today for the Solutions of Tomorrow.” The sessions will also be streamed live, enabling virtual viewing.
In a press release, GOED’s managing director, Ellen Schutt, said, “Right now, there are challenges within the omega-3 marketplace, and it’s important that we as an industry work together to ensure a healthy future. The GOED Exchange event has historically been a great venue for collaboration among key executives in the omega-3 space, and the upcoming conference is more important than ever so we discuss issues and brainstorm solutions together.”
Agenda highlights include:
To register for the event, click here.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.